🇺🇸 FDA
Patent

US 10307477

Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment

granted A61KA61K2039/5256A61K2039/545

Quick answer

US patent 10307477 (Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment) held by The United States of America as represented by the Secretary of the Army expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/5256, A61K2039/545, A61K2039/57, A61K2039/575